Figure 5From: Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study Overall Medication Preference. Patient and physician overall medication preference at week 12 of treatment with lanthanum carbonate (intent to treat population). *P< 0.0001 from binomial test procedure with null hypothesis; proportion = 0.5.Back to article page